Special Appointment by Dean Pezzuto
Adjunct Professor of Pharmaceutical Science
Email: diren.beyoglu@wne.edu
Internationally renowned researcher in metabolomics and liver disease with a strong background in pharmacy and food toxicology. Reported the first joint metabolomics and transcriptomics investigation of hepatocellular carcinoma and for more than a decade employed mass spectrometry-based metabolomics and lipidomics to interrogate mechanisms of liver disease progression. Dr. Beyoğlu obtained a BSc in pharmacy, an MSc and PhD in pharmaceutical toxicology from Marmara University, Istanbul, Türkiye. From 2011 she worked in the hepatology research group at the University of Bern, Switzerland and was appointed in 2018 as associate professor and associate director of the Arthur G. Zupko Institute for Systems Pharmacology and Pharmacogenomics at Long Island University, Brooklyn. Dr. Beyoğlu specializes in the use of liquid chromatography-mass spectrometry and gas chromatography-mass spectrometry-based metabolomics and lipidomics in the context of translational research. This has been applied initially in Bern in hepatology and leukemia patients using biobanked plasma, urine and tissue samples. This paradigm can be extended to translational research in any clinical specialty. Using metabolomic and lipidomic approaches, her research has advanced understanding of the underlying mechanisms of multiple liver diseases, including chronic hepatitis B and C, fibrosis, cirrhosis and hepatocellular carcinoma. It is anticipated that such novel molecular mechanisms may lead to new druggable solutions to liver diseases that affect hundreds of millions of persons worldwide